Clinical characteristics of anti-Jo-1-positive interstitial lung disease

被引：0
|
作者：
Chang, Shihwan [1 ]
Shin, Mi Hwa [1 ]
Shin, Ju Hye [1 ]
Park, Moo Suk [1 ]
机构：
[1] Yonsei Univ, Severance Hosp, Inst Chest Dis, Div Pulmonol,Dept Internal Med,Coll Med, Seoul, South Korea
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
D O I：
10.1183/13993003.congress-2019.PA5183
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA5183
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Atypical Presentation Of Anti-Jo-1 Positive Interstitial Lung Disease
    Gandhi, V.
    Hewston, M.
    Fasanya, A.
    Sharara, R.
    Cheema, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [2] Sera From Anti-Jo-1-Positive Patients With Polymyositis and Interstitial Lung Disease Induce Expression of Intercellular Adhesion Molecule 1 in Human Lung Endothelial Cells
    Helmers, Sevim Barbasso
    Englund, Pernilla
    Engstrom, Marianne
    Ahlin, Erik
    Fathi, Maryam
    Janciauskiene, Sabina
    Heimburger, Mikael
    Ronnelid, Johan
    Lundberg, Ingrid E.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (08): : 2524 - 2530
  • [3] Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome
    Zamora, Ana C.
    Hoskote, Sumedh S.
    Abascal-Bolado, Beatriz
    White, Darin
    Cox, Christian W.
    Ryu, Jay H.
    Moua, Teng
    RESPIRATORY MEDICINE, 2016, 118 : 39 - 45
  • [4] INTERSTITIAL LUNG-DISEASE AS THE PRESENTATION OF ANTI-JO-1 POSITIVE POLYMYOSITIS
    NASH, P
    SCHRIEBER, L
    WEBB, J
    CLINICAL RHEUMATOLOGY, 1987, 6 (02) : 282 - 286
  • [5] The long-term outcome of anti-Jo-1-positive inflammatory myopathies
    Späth, M
    Schröder, M
    Schlotter-Weigel, B
    Walter, MC
    Hautmann, H
    Leinsinger, G
    Pongratz, D
    Müller-Felber, W
    JOURNAL OF NEUROLOGY, 2004, 251 (07) : 859 - 864
  • [6] ANTI-JO-1-POSITIVE POLYMYOSITIS WITH INTERSTITIAL ALVEOLITIS AND PERICARDIAL-EFFUSION - REVIEW OF A 3-YEAR TREATMENT
    KRAJNC, I
    WIENER KLINISCHE WOCHENSCHRIFT, 1995, 107 (19) : 590 - 592
  • [7] Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients
    Andrea Váncsa
    I. Csípő
    J. Németh
    K. Dévényi
    L. Gergely
    K. Dankó
    Rheumatology International, 2009, 29 : 989 - 994
  • [8] The long-term outcome of anti-Jo-1-positive inflammatory myopathies
    Michael Späth
    Mira Schröder
    Beate Schlotter-Weigel
    Maggie C. Walter
    Hubert Hautmann
    Gerda Leinsinger
    Dieter Pongratz
    Wolfgang Müller-Felber
    Journal of Neurology, 2004, 251 : 859 - 864
  • [9] Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients
    Vancsa, Andrea
    Csipo, I.
    Nemeth, J.
    Devenyi, K.
    Gergely, L.
    Danko, K.
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (09) : 989 - 994
  • [10] Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients
    Hulejova, H.
    Krystufkova, O.
    Mann, H.
    Klein, M.
    Pavlickova, K.
    Zamecnik, J.
    Vencovsky, J.
    Senolt, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 222 - 229
12345